PedsQL™ sickle cell disease module: feasibility, reliability, and validity. - Wikidata - wikimedia - TriplyDB

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

http://www.wikidata.org/entity/Q35545910

about

Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease Care Coordination for Children With Sickle Cell Disease: A Longitudinal Study of Parent Perspectives and Acute Care Utilization Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease.Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.Disease Knowledge, Illness Perceptions, and Quality of Life in Adolescents With Sickle Cell Disease: Is There a Link?Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial.PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls.PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.Feasibility of Home-Based Computerized Working Memory Training With Children and Adolescents With Sickle Cell Disease.Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue.HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease.Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

P2860

Q33755816-2865B1AC-7498-4FFE-A7E3-13D14F7B670E Q33791528-965B5936-3334-45ED-9D9A-59D335EC35BC Q34725738-A675B3C4-CA4B-4616-9C06-638592DF8E01 Q35007607-7B7ADAE5-9FCD-4299-8D6D-ECF6F34F748C Q36115743-7D23530F-077B-44AB-B8BF-805CF9FED95C Q36803332-17D2E031-F598-46E6-8C82-E47A7F3042B2 Q37027205-CDA56BEA-5254-49E4-AF4A-5CAD9341BF5F Q37258852-28782962-CCF8-4F96-ACDE-9F52F94D2C51 Q37322373-406E7FE0-FB17-41F1-ABB8-9A1F9DDB7615 Q37359944-448CFE95-6648-4F82-969A-B6893A70A706 Q38683376-382CCA3A-A2A4-4967-9564-B907ADF80146 Q39495873-E39C82EB-CBFF-445D-A280-B35692BBBE17 Q41592113-63716FEC-40C5-43F7-87B0-D7433D7DCAEC Q44047673-5CF34E8A-9B2C-4EE1-8D99-9DA379C7E0E1 Q47642462-89F268E0-06C6-4537-9F5F-02A1EE1C644C Q48067426-902C362C-C4A5-44D6-8B85-6C2C48D37F21 Q48353369-48D6FAC5-EB81-43CC-A93C-42B481FB57FC Q50509331-D80AADD7-C95F-46D8-9885-87E22CD0B709 Q51676994-8E3346A2-B35E-4DF1-B7BE-1515D74F744B Q52639727-7A29F9E2-74E4-4C9B-9633-58BAE0E328CD Q52728984-2D9D761E-C1BE-4E76-BE7C-A72A14F08BB0 Q55037457-6BFC2612-DADB-403A-B7ED-ABDE355F55A4 Q55250719-BBEEB889-B4F6-433B-A597-92C8ECAA54C4 Q58765141-2F58C896-9C28-4F42-83D4-A26E7C33DDA8

P2860

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

http://www.wikidata.org/entity/Q35545910

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@ast

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@en

type

label

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@ast

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@en

prefLabel

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@ast

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@en

P1433

Q35545910-C457C4E9-8445-41D5-867E-883402224791

P1476

Q35545910-8BB68DB0-66FE-44C5-9E02-EE2138426028

P2093

Q35545910-37DD2DD7-6D05-44F0-8149-583BADB644FB

Q35545910-51A24A4D-C702-4F81-A567-7F21C398AFAB

Q35545910-5540547D-7652-4529-8D37-41E6CCBAF875

Q35545910-67182728-1DE7-4476-9563-334F55C138BC

Q35545910-7D99DDD1-AA5D-4599-89D1-F1302E1AA82D

Q35545910-BA48CE82-3C7E-4560-BD49-B3C81B8173D4

Q35545910-BFE9B3CA-602F-4C4D-B5DE-F03B39F4461B

Q35545910-F3989E64-8B2E-483C-9052-FB32FEDF079A

P2860

Q35545910-01EC0C8F-575D-4241-9E78-6529DC16B5F2

Q35545910-0C682EAF-56DA-4413-9B55-0390C8FFA9D2

Q35545910-20B78494-9B13-479C-ADB2-8F4A990DBA5E

Q35545910-2375A192-445A-4AD0-AA69-4FB52CEDF8D4

Q35545910-26FD1990-B335-4287-B2FE-6B74D05B9648

Q35545910-2D80842B-6073-43EA-89EC-10C695F1EFB4

Q35545910-2FFC9679-D2CE-437D-86D5-F7D3A204780D

Q35545910-31ADD0A5-E795-4C2D-B473-CF77C8875831

Q35545910-4C5F774A-9E79-4396-8B7F-3C0A52518064

Q35545910-4CBEDC49-54C2-4318-8A1E-7FDD3CEB4F7D

P304

Q35545910-6AE042A7-70FC-4BA2-B349-6287FA8A6782

P31

Q35545910-54F55D1C-8016-456B-A62D-05166D522BF8

P356

Q35545910-C3ADCF9E-3995-4C1B-BD16-2B4098685490

P433

Q35545910-BBAC8140-00B0-4A61-94DF-A6C51111553F

P478

Q35545910-B41A6A51-B295-49E6-893C-2329B94C5A32

P577

Q35545910-7B1F0FB8-456A-4ECC-9C50-68B3354D1AFA

P698

Q35545910-6045B62C-CACF-4E62-AF4B-30F72F214882

P921

Q35545910-2BE5E8F6-97A7-4BB8-9BCA-8B76611DEAC7

P932

Q35545910-3E569C57-3FA2-436F-BFB2-589A98F984D1

P356

P1433

Pediatric Blood & Cancer

P1476

PedsQL™ sickle cell disease module: feasibility, reliability, and validity.

@en

P2093

Bogdan Dinu

http://www.w3.org/2001/XMLSchema#string

Christy Bemrich-Stolz

http://www.w3.org/2001/XMLSchema#string

Cristiane B Bendo

http://www.w3.org/2001/XMLSchema#string

James W Varni

http://www.w3.org/2001/XMLSchema#string

Julie A Panepinto

http://www.w3.org/2001/XMLSchema#string

Sandra Sherman-Bien

http://www.w3.org/2001/XMLSchema#string

Sylvia Torres

http://www.w3.org/2001/XMLSchema#string

Timothy L McCavit

http://www.w3.org/2001/XMLSchema#string

P2860

The intraclass correlation coefficient as a measure of reliability

Coefficient alpha and the internal structure of tests

Cognitive interviewing methodology in the development of a pediatric item bank: a patient reported outcomes measurement information system (PROMIS) study.

PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank

Impact of family income and sickle cell disease on the health-related quality of life of children.

Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales.

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

Health-related quality of life in children and adolescents with sickle cell disease

P304

1338-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24491

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23441057

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

4412167

http://www.w3.org/2001/XMLSchema#string